Literature DB >> 32832864

Structure, Function, and Therapeutic Potential of the Trefoil Factor Family in the Gastrointestinal Tract.

Nayara Braga Emidio1, Stuart M Brierley2,3,4, Christina I Schroeder1,5, Markus Muttenthaler6,1.   

Abstract

Trefoil factor family peptides (TFF1, TFF2, and TFF3) are key players in protecting, maintaining, and repairing the gastrointestinal tract. Accordingly, they have the therapeutic potential to treat and prevent a variety of gastrointestinal disorders associated with mucosal damage. TFF peptides share a conserved motif, including three disulfide bonds that stabilize a well-defined three-loop-structure reminiscent of a trefoil. Although multiple functions have been described for TFF peptides, their mechanisms at the molecular level remain poorly understood. This review presents the status quo of TFF research relating to gastrointestinal disorders. Putative TFF receptors and protein partners are described and critically evaluated. The therapeutic potential of these peptides in gastrointestinal disorders where altered mucosal biology plays a crucial role in the underlying etiology is discussed. Finally, areas of investigation that require further research are addressed. Thus, this review provides a comprehensive update on TFF literature as well as guidance toward future research to better understand this peptide family and its therapeutic potential for the treatment of gastrointestinal disorders.
Copyright © 2020 American Chemical Society.

Entities:  

Year:  2020        PMID: 32832864      PMCID: PMC7432662          DOI: 10.1021/acsptsci.0c00023

Source DB:  PubMed          Journal:  ACS Pharmacol Transl Sci        ISSN: 2575-9108


  175 in total

1.  Effect of trefoil factors on the viscoelastic properties of mucus gels.

Authors:  L Thim; F Madsen; S S Poulsen
Journal:  Eur J Clin Invest       Date:  2002-07       Impact factor: 4.686

2.  Tissue localization of human trefoil factors 1, 2, and 3.

Authors:  Jens Madsen; Ole Nielsen; Ida Tornøe; Lars Thim; Uffe Holmskov
Journal:  J Histochem Cytochem       Date:  2007-01-22       Impact factor: 2.479

3.  TFF3-peptide increases transepithelial resistance in epithelial cells by modulating claudin-1 and -2 expression.

Authors:  Dirk Meyer zum Büschenfelde; Rudolf Tauber; Otmar Huber
Journal:  Peptides       Date:  2006-10-02       Impact factor: 3.750

4.  Human gastric TFF2 peptide contains an N-linked fucosylated N,N'-diacetyllactosediamine (LacdiNAc) oligosaccharide.

Authors:  Franz-Georg Hanisch; Hubert Ragge; Thomas Kalinski; Frank Meyer; Hubert Kalbacher; Werner Hoffmann
Journal:  Glycobiology       Date:  2012-09-20       Impact factor: 4.313

5.  Interaction between TFF1, a gastric tumor suppressor trefoil protein, and TFIZ1, a brichos domain-containing protein with homology to SP-C.

Authors:  Bruce R Westley; S Michael Griffin; Felicity E B May
Journal:  Biochemistry       Date:  2005-06-07       Impact factor: 3.162

6.  Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor.

Authors:  H Mashimo; D C Wu; D K Podolsky; M C Fishman
Journal:  Science       Date:  1996-10-11       Impact factor: 47.728

7.  Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy.

Authors:  Douglas E Peterson; Nicholas P Barker; Lilia I Akhmadullina; Irina Rodionova; Nailya Z Sherman; Irina S Davidenko; Galina N Rakovskaya; Eugeny A Gotovkin; Sergey A Shinkarev; Mikhail V Kopp; Eugeny P Kulikov; Vladimir M Moiseyenko; Joseph M Gertner; Igor Firsov; Tamara Tuleneva; Alexander Yarosh; Chee-Wai Woon
Journal:  J Clin Oncol       Date:  2009-07-27       Impact factor: 44.544

8.  Molecular mechanisms involved in TFF3 peptide-mediated modulation of the E-cadherin/catenin cell adhesion complex.

Authors:  Dirk Meyer zum Büschenfelde; Heinz Hoschützky; Rudolf Tauber; Otmar Huber
Journal:  Peptides       Date:  2004-05       Impact factor: 3.750

9.  Pharmacokinetics of trefoil peptides and their stability in gastrointestinal contents.

Authors:  Stine Kjellev; Else Marie Vestergaard; Ebba Nexø; Peter Thygesen; Maria S Eghøj; Palle B Jeppesen; Lars Thim; Nis Borbye Pedersen; Steen Seier Poulsen
Journal:  Peptides       Date:  2007-03-31       Impact factor: 3.750

10.  Intestinal trefoil factor/TFF3 promotes re-epithelialization of corneal wounds.

Authors:  Friedrich P Paulsen; Chee-Wai Woon; Deike Varoga; Anne Jansen; Fabian Garreis; Kristin Jäger; Marita Amm; Daniel K Podolsky; Philipp Steven; Nicholas P Barker; Saadettin Sel
Journal:  J Biol Chem       Date:  2008-03-07       Impact factor: 5.157

View more
  9 in total

1.  Pan-Cancer Single-Cell Analysis Reveals the Core Factors and Pathway in Specific Cancer Stem Cells of Upper Gastrointestinal Cancer.

Authors:  Leijie Li; Yujia Zhang; Yongyong Ren; Zhiwei Cheng; Yuening Zhang; Xinbo Wang; Hongyu Zhao; Hui Lu
Journal:  Front Bioeng Biotechnol       Date:  2022-05-13

Review 2.  Gut homeostasis, injury, and healing: New therapeutic targets.

Authors:  Sema Oncel; Marc D Basson
Journal:  World J Gastroenterol       Date:  2022-05-07       Impact factor: 5.374

3.  On the Utility of Chemical Strategies to Improve Peptide Gut Stability.

Authors:  Thomas Kremsmayr; Aws Aljnabi; Juan B Blanco-Canosa; Hue N T Tran; Nayara Braga Emidio; Markus Muttenthaler
Journal:  J Med Chem       Date:  2022-04-14       Impact factor: 8.039

4.  TFF1 in Aqueous Humor-A Potential New Biomarker for Retinoblastoma.

Authors:  Maike Anna Busch; André Haase; Natalia Miroschnikov; Annika Doege; Eva Biewald; Nikolaos E Bechrakis; Manfred Beier; Deniz Kanber; Dietmar Lohmann; Klaus Metz; Nicole Dünker
Journal:  Cancers (Basel)       Date:  2022-01-28       Impact factor: 6.639

5.  Upregulation of antimicrobial peptide expression in slc26a3-/- mice with colonic dysbiosis and barrier defect.

Authors:  Archana Kini; Bei Zhao; Marijana Basic; Urmi Roy; Aida Iljazovic; Ivan Odak; Zhenghao Ye; Brigitte Riederer; Gabriella Di Stefano; Dorothee Römermann; Christian Koenecke; André Bleich; Till Strowig; Ursula Seidler
Journal:  Gut Microbes       Date:  2022 Jan-Dec

6.  Association of functional genetic variants in TFF1 and nephrolithiasis risk in a Chinese population.

Authors:  Qiangdong Wang; Yan Jiang; Mulong Du; Lei Yang; Qinbo Yuan
Journal:  BMC Urol       Date:  2022-08-20       Impact factor: 2.090

7.  CD147 receptor is essential for TFF3-mediated signaling regulating colorectal cancer progression.

Authors:  Hong-Yong Cui; Shi-Jie Wang; Fei Song; Xu Cheng; Gang Nan; Yu Zhao; Mei-Rui Qian; Xi Chen; Jia-Yue Li; Fen-Ling Liu; Yu-Meng Zhu; Ruo-Fei Tian; Bin Wang; Bin Wu; Yang Zhang; Xiu-Xuan Sun; Ting Guo; Xiang-Min Yang; Hai Zhang; Ling Li; Jing Xu; Hui-Jie Bian; Jian-Li Jiang; Zhi-Nan Chen
Journal:  Signal Transduct Target Ther       Date:  2021-07-14

8.  Chemical Synthesis of TFF3 Reveals Novel Mechanistic Insights and a Gut-Stable Metabolite.

Authors:  Nayara Braga Emidio; Rajeshwari Meli; Hue N T Tran; Hayeon Baik; Séverine Morisset-Lopez; Alysha G Elliott; Mark A T Blaskovich; Sabrina Spiller; Annette G Beck-Sickinger; Christina I Schroeder; Markus Muttenthaler
Journal:  J Med Chem       Date:  2021-06-18       Impact factor: 7.446

Review 9.  Diet Impact on Obesity beyond Calories and Trefoil Factor Family 2 (TFF2) as an Illustration: Metabolic Implications and Potential Applications.

Authors:  Abdelaziz Ghanemi; Mayumi Yoshioka; Jonny St-Amand
Journal:  Biomolecules       Date:  2021-12-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.